Ilex Medical Ltd. (ILX)
TASE
5,039.00
-38.00 (-0.75%)
Closed
Aug 25, 2026
Day's Range
4,674.005,285.00
52 wk Range
4,501.007,085.00
Financial Statements - ILX - Ilex Medical Ltd.
Revenue
930.83M▲ 1.1%
Net Income
55.55M▲ 42.5%Net Margin 6.0%
EBITDA
111.12M▼ 0.8%
Free Cash Flow
42.80M▼ 11.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 930.83M | 920.37M | 930.89M | 872.54M | 1.06B | 946.45M |
| Cost of Goods | 718.95M | 704.06M | 699.02M | 587.44M | 681.61M | 675.43M |
| Gross Profit | 211.88M | 216.31M | 231.86M | 285.10M | 379.38M | 271.02M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 55.94M | 64.72M | 73.15M | 137.34M | 244.33M | 144.72M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 74.13M | 61.59M | 69.40M | 136.74M | 255.34M | 153.79M |
| Income Tax | 18.58M | 15.89M | 18.51M | 34.61M | 57.86M | 27.83M |
| Net Income | 55.55M | 38.98M | 50.88M | 102.12M | 197.48M | 125.96M |
| EPS Basic | 4.97 | 3.49 | 4.55 | 9.05 | 17.51 | 11.3 |
| EPS Diluted | 4.97 | 3.49 | 4.55 | 9.05 | 17.5 | 11.24 |
| Basic Shares Outstanding | 11.18M | 11.18M | 11.19M | 11.27M | 11.28M | 10.67M |
| Diluted Shares Outstanding | 11.18M | 11.18M | 11.19M | 11.27M | 11.28M | 10.67M |
| Ebit | 76.33M | 64.02M | 71.27M | 138.34M | 257.35M | 156.18M |
| Ebitda | 111.12M | 111.97M | 116.58M | 179.06M | 301.56M | 191.69M |
| Net Income Continuous Operations | 74.13M | 54.88M | 69.40M | 136.74M | 255.34M | 153.79M |
| Minority Interests | - | - | - | 0 | 0 | -5.34M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
